Hineline Lawrence J.'s Form 4 filing
Intra-Cellular Therapies, Inc. (ITCI) · filed Jun 16, 2023
- Accession no.
- 0001209191-23-037968
- Filed
- Jun 16, 2023
- Trade date
- Jun 14, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 7 non-derivative transactions and 4 derivative transactions. Open-market sales total $5.24M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hineline Lawrence J.CIK 0001585697 | Officer (SVP of Finance CFO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 14, 2023 | Common Stock | MOption exerciseAcquired | +40,472 | $53.63 | +$2,170,513.36 | 40,472 | Direct | |
| Jun 14, 2023 | Common Stock | MOption exerciseAcquired | +25,082 | $23.94 | +$600,463.08 | 65,554 | Direct | |
| Jun 14, 2023 | Common Stock | MOption exerciseAcquired | +11,762 | $36.89 | +$433,900.18 | 77,316 | Direct | |
| Jun 14, 2023 | Common Stock | MOption exerciseAcquired | +4,538 | $56.73 | +$257,440.74 | 81,854 | Direct | |
| Jun 14, 2023 | Common Stock | SSaleDisposed | −34,227 | $63.35 | −$2,168,280.45 | 47,627 | Direct | |
| Jun 14, 2023 | Common Stock | SSaleDisposed | −44,035 | $64.37 | −$2,834,532.95 | 3,592 | Direct | |
| Jun 14, 2023 | Common Stock | SSaleDisposed | −3,592 | $65.01 | −$233,515.92 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 14, 2023 | Common Stock | MOption exerciseDisposed | −40,472 | $0.00 | $0 | 0 | Direct | |
| Jun 14, 2023 | Common Stock | MOption exerciseDisposed | −25,082 | $0.00 | $0 | 0 | Direct | |
| Jun 14, 2023 | Common Stock | MOption exerciseDisposed | −11,762 | $0.00 | $0 | 5,882 | Direct | |
| Jun 14, 2023 | Common Stock | MOption exerciseDisposed | −4,538 | $0.00 | $0 | 9,078 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.